179 related articles for article (PubMed ID: 10662802)
1. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides.
Pique C; Ureta-Vidal A; Gessain A; Chancerel B; Gout O; Tamouza R; Agis F; Dokhélar MC
J Exp Med; 2000 Feb; 191(3):567-72. PubMed ID: 10662802
[TBL] [Abstract][Full Text] [Related]
2. In vivo production of Rof and Tof proteins of HTLV type 1: evidence from cytotoxic T lymphocytes.
Pique C; Dokhelar MC
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1783-6. PubMed ID: 11080827
[No Abstract] [Full Text] [Related]
3. In vitro and in vivo functional analysis of human T cell lymphotropic virus type 1 pX open reading frames I and II.
Lairmore MD; Albrecht B; D'Souza C; Nisbet JW; Ding W; Bartoe JT; Green PL; Zhang W
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1757-64. PubMed ID: 11080823
[TBL] [Abstract][Full Text] [Related]
4. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S
Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511
[TBL] [Abstract][Full Text] [Related]
5. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion.
Silverman LR; Phipps AJ; Montgomery A; Ratner L; Lairmore MD
J Virol; 2004 Apr; 78(8):3837-45. PubMed ID: 15047799
[TBL] [Abstract][Full Text] [Related]
6. Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy.
Goon PK; Biancardi A; Fast N; Igakura T; Hanon E; Mosley AJ; Asquith B; Gould KG; Marshall S; Taylor GP; Bangham CR
J Infect Dis; 2004 Jun; 189(12):2294-8. PubMed ID: 15181578
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines.
Cereseto A; Berneman Z; Koralnik I; Vaughn J; Franchini G; Klotman ME
Leukemia; 1997 Jun; 11(6):866-70. PubMed ID: 9177442
[TBL] [Abstract][Full Text] [Related]
8. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
[TBL] [Abstract][Full Text] [Related]
9. Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes.
Robek MD; Wong FH; Ratner L
J Virol; 1998 May; 72(5):4458-62. PubMed ID: 9557741
[TBL] [Abstract][Full Text] [Related]
10. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.
Bartoe JT; Albrecht B; Collins ND; Robek MD; Ratner L; Green PL; Lairmore MD
J Virol; 2000 Feb; 74(3):1094-100. PubMed ID: 10627519
[TBL] [Abstract][Full Text] [Related]
11. The MHC class I heavy chain is a common target of the small proteins encoded by the 3' end of HTLV type 1 and HTLV type 2.
Johnson JM; Mulloy JC; Ciminale V; Fullen J; Nicot C; Franchini G
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1777-81. PubMed ID: 11080826
[TBL] [Abstract][Full Text] [Related]
12. Insights on the pathogenicity of human T-lymphotropic/leukemia virus types I and II.
Cereseto A; Mulloy JC; Franchini G
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S69-75. PubMed ID: 8797707
[TBL] [Abstract][Full Text] [Related]
13. Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients.
Novaes R; Freire-de-Lima CG; de Albuquerque RC; Affonso-Mitidieri OR; Espindola O; Lima MA; de Andrada Serpa MJ; Echevarria-Lima J
Immunobiology; 2013 Sep; 218(9):1166-74. PubMed ID: 23669236
[TBL] [Abstract][Full Text] [Related]
14. Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection.
Abdelbary NH; Abdullah HM; Matsuzaki T; Hayashi D; Tanaka Y; Takashima H; Izumo S; Kubota R
J Infect Dis; 2011 Apr; 203(7):948-59. PubMed ID: 21402546
[TBL] [Abstract][Full Text] [Related]
15. Human T-lymphotropic virus type I (HTLV-I)-specific CD8+ cells accumulate in the lungs of patients infected with HTLV-I with pulmonary involvement.
Kawabata T; Higashimoto I; Takashima H; Izumo S; Kubota R
J Med Virol; 2012 Jul; 84(7):1120-7. PubMed ID: 22585731
[TBL] [Abstract][Full Text] [Related]
16. Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.
Arnulf B; Thorel M; Poirot Y; Tamouza R; Boulanger E; Jaccard A; Oksenhendler E; Hermine O; Pique C
Leukemia; 2004 Jan; 18(1):126-32. PubMed ID: 14574331
[TBL] [Abstract][Full Text] [Related]
17. Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.
Bindhu M; Nair A; Lairmore MD
Front Biosci; 2004 Sep; 9():2556-76. PubMed ID: 15358581
[TBL] [Abstract][Full Text] [Related]
18. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
[TBL] [Abstract][Full Text] [Related]
19. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.
Etoh K; Tamiya S; Yamaguchi K; Okayama A; Tsubouchi H; Ideta T; Mueller N; Takatsuki K; Matsuoka M
Cancer Res; 1997 Nov; 57(21):4862-7. PubMed ID: 9354450
[TBL] [Abstract][Full Text] [Related]
20. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
